当前位置:首页 - 行情中心 - 和邦生物(603077) - 财务分析 - 现金流量表

和邦生物

(603077)

  

流通市值:153.66亿  总市值:153.66亿
流通股本:88.31亿   总股本:88.31亿

现金流量表

报告期2025-03-312024-12-312024-09-302024-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金1,634,049,492.447,480,057,304.35,238,258,922.963,410,337,467.35
收到的税费返还13,782,527.2337,242,301.9625,806,199.314,182,018.71
收到其他与经营活动有关的现金15,728,987.06162,332,673.3466,223,464.4441,925,822.13
经营活动现金流入的平衡项目0000
经营活动现金流入小计1,663,561,006.737,679,632,279.65,330,288,586.73,466,445,308.19
购买商品、接受劳务支付的现金1,469,592,018.355,829,688,440.224,386,716,484.232,828,622,315.76
支付给职工以及为职工支付的现金171,905,988.29884,036,822.91704,791,211.13514,802,120.75
支付的各项税费58,277,337.98345,101,527.6260,840,307.38159,094,692.41
支付其他与经营活动有关的现金18,377,070.81152,874,101.7115,163,399.4867,410,294.49
经营活动现金流出的平衡项目0000
经营活动现金流出小计1,718,152,415.437,211,700,892.435,467,511,402.223,569,929,423.41
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额-54,591,408.7467,931,387.17-137,222,815.52-103,484,115.22
二、投资活动产生的现金流量:
收回投资收到的现金-27,523,493.8522,581,922.29,279,236.67
取得投资收益收到的现金1,120,0001,806,347.01843,852.71842,619.47
处置固定资产、无形资产和其他长期资产收回的现金净额565,396.012,698,447.4629,69920,000
收到的其他与投资活动有关的现金29,165,751.3713,543,230.71700,000300,000
投资活动现金流入的平衡项目0000
投资活动现金流入小计30,851,147.3845,571,519.0324,155,473.9110,441,856.14
购建固定资产、无形资产和其他长期资产支付的现金330,976,242.351,116,226,426.99545,005,408.01333,323,483.58
投资支付的现金26,000,000283,780,066.18203,931,308.21176,872,444.3
支付其他与投资活动有关的现金11,955,831.432,684,506.6339,728,300.891,200,000
投资活动现金流出的平衡项目0000
投资活动现金流出小计368,932,073.751,432,690,999.8788,665,017.11511,395,927.88
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-338,080,926.37-1,387,119,480.77-764,509,543.2-500,954,071.74
三、筹资活动产生的现金流量:
取得借款收到的现金2,234,676,713.767,981,179,805.552,710,072,723.292,335,268,976.08
收到其他与筹资活动有关的现金44,531,637.09159,130,243.5159,130,243.5159,130,243.5
筹资活动现金流入平衡项目0000
筹资活动现金流入小计2,279,208,350.858,140,310,049.052,869,202,966.792,494,399,219.58
偿还债务支付的现金1,323,196,478.751,491,322,847.51,243,925,323.58956,620,672.93
分配股利、利润或偿付利息支付的现金30,496,071.9246,664,095.3361,649,487.1538,023,920.76
支付其他与筹资活动有关的现金320,494,433.531,555,112,829.41,195,922,516.17949,864,753.71
筹资活动现金流出平衡项目0000
筹资活动现金流出小计1,674,186,984.183,293,099,772.232,501,497,326.91,944,509,347.4
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额605,021,366.674,847,210,276.82367,705,639.89549,889,872.18
四、汇率变动对现金及现金等价物的影响1,784,946.918,709,035.49-4,277,0814,612,832.96
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额214,133,978.53,946,731,218.71-538,303,799.83-49,935,481.82
加:期初现金及现金等价物余额6,851,563,060.792,904,831,842.082,904,831,842.082,904,831,842.08
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额7,065,697,039.296,851,563,060.792,366,528,042.252,854,896,360.26
补充资料:
净利润--70,744,609.93-188,048,359.55
资产减值准备-128,021,291.49-3,927,034.19
固定资产和投资性房地产折旧-920,635,825.49-466,090,074.23
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-920,635,825.49-466,090,074.23
无形资产摊销-54,748,148.57-24,901,450.44
长期待摊费用摊销-5,000,881.64-608,590.44
处置固定资产、无形资产和其他长期资产的损失--1,168,756.89-36,244.07
固定资产报废损失-131,511.32-114,297.82
财务费用-62,136,404.75-32,947,142.56
投资损失-5,670,300.35-300,197.85
递延所得税--69,094,247.39-10,350,208.16
其中:递延所得税资产减少--74,035,323.03--950,521.42
递延所得税负债增加-4,941,075.64-11,300,729.58
存货的减少--240,336,248.6--250,941,175.19
经营性应收项目的减少--53,392,819.13--1,351,744,882.42
经营性应付项目的增加--319,993,941.36-760,721,062.12
其他-31,826,048.72--
现金的期末余额-6,851,563,060.79-2,854,896,360.26
减:现金的期初余额-2,904,831,842.08-2,904,831,842.08
公告日期2025-04-292025-04-292024-10-312024-08-30
审计意见(境内)标准无保留意见
TOP↑